financetom
Business
financetom
/
Business
/
Whitestone REIT Q4 Core FFO, Revenue Higher; Sets 2024 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Whitestone REIT Q4 Core FFO, Revenue Higher; Sets 2024 Outlook
Mar 6, 2024 2:23 PM

05:04 PM EST, 03/06/2024 (MT Newswires) -- Whitestone REIT ( WSR ) late Wednesday reported Q4 core funds from operations of $0.24 per diluted share, compared with $0.23 a year earlier.

Analysts polled by Capital IQ expected $0.25.

Revenue for the quarter ended Dec. 31 was $37.5 million, up from $34.9 million a year earlier.

Analysts expected $37.4 million.

For 2024, the company is projecting core FFO of $0.98 to $1.04 per share.

Analysts are looking for $1.04.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson to Acquire V-Wave for up to $1.7 Billion
Johnson & Johnson to Acquire V-Wave for up to $1.7 Billion
Aug 20, 2024
08:00 AM EDT, 08/20/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Tuesday it agreed to acquire medical device company V-Wave for an upfront payment of $600 million, with additional milestone payments of up to $1.1 billion. Following deal completion, expected before the end of 2024, V-Wave will be integrated into Johnson & Johnson MedTech, Johnson & Johnson...
--Street Color: Stellantis to Delay Reopening of Belvidere Plant
--Street Color: Stellantis to Delay Reopening of Belvidere Plant
Aug 20, 2024
08:37 AM EDT, 08/20/2024 (MT Newswires) -- Price: 16.48, Change: +0.19, Percent Change: +1.17 ...
Amneal Pharmaceuticals Says US FDA Approves Generic Drug Application for Propofol
Amneal Pharmaceuticals Says US FDA Approves Generic Drug Application for Propofol
Aug 20, 2024
08:32 AM EDT, 08/20/2024 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Tuesday that its abbreviated new drug application for the single-dose formulation of anesthetic propofol has gained approval from the US Food and Drug Administration. The company said it expects to launch propofol in Q4. Shares of the company were up 1.4% in recent Tuesday premarket activity. Price:...
Diversified Energy to Acquire Natural Gas Assets in Texas
Diversified Energy to Acquire Natural Gas Assets in Texas
Aug 20, 2024
08:34 AM EDT, 08/20/2024 (MT Newswires) -- Diversified Energy ( DEC ) said Tuesday it will acquire operated natural gas assets in eastern Texas as well as an undeveloped area, which will be bought together with a third party development firm, from an unnamed regional operator under a conditional purchase and sale agreement. The operated natural gas assets include about...
Copyright 2023-2026 - www.financetom.com All Rights Reserved